(Q39025763)
Statements
1 reference
Impact of ibrutinib and idelalisib on the pharmaceutical cost of treating chronic lymphocytic leukemia at the individual and societal levels (English)
1 reference
Tait D Shanafelt
1 reference
Tim G Call
1 reference
Susan L Slager
1 reference
Kari G Chaffee
1 reference
Neil E Kay
1 reference
Bijan J Borah
1 reference
Heidi D Finnes
1 reference
Wei Ding
1 reference
Jose F Leis
1 reference
Asher A Chanan-Khan
1 reference
Sameer A Parikh
1 reference
24 March 2015
1 reference
1 reference
11
1 reference
3
1 reference
252-258
1 reference
Identifiers
1 reference
1 reference